Ruth Madera-Sandoval

Dr. Ruth Madera-Sandoval

Instituto Mexicano del Seguro Social
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2015 in Ecotoxicology
Verified
Journal Article
Closed access
PDF file
HOHugo F. Olivares-Rubio
Hugo F. Olivares-Rubio
RDRicardo Dzul-Caamal
Ricardo Dzul-Caamal
MGMaría Esperanza Gallegos-Rangel
María Esperanza Gallegos-Rangel
Ruth Madera-SandovalRuth Madera-Sandoval
Ruth Madera-Sandoval
MDMaría Lilia Domínguez-López
María Lilia Domínguez-López
AVArmando Vega-Loṕez
Armando Vega-Loṕez

15 April 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
JMJosé Esteban Muñoz Medina
José Esteban Muñoz Medina
CGConcepción Grajales-Muñiz
Concepción Grajales-Muñiz
ASAngel Gustavo Salas-Lais
Angel Gustavo Salas-Lais
LMLarissa Fernandes Matano
Larissa Fernandes Matano
CLConstantino López-Macías
Constantino López-Macías
VBVíctor Hugo Borja-Aburto
Víctor Hugo Borja-Aburto
Until recently, the incidence of COVID-19 was primarily estimated using molecular diagnostic methods. However, the number of cases is vastly underreported using these methods. Seroprevalence studies estimate cumulative infection incidences and allow monitoring of transmission dynamics, and the presence of neutralizing antibodies in the population. In February 2020, the Mexican Social Security Institute began conducting anonymous unrelated sampling of residual sera from specimens across the country, excluding patients with fever within the previous two weeks and/or patients with an acute respiratory infection. Sampling was carried out weekly and began 17 days before Mexico’s first officially confirmed case. The 24,273 sera obtained were analyzed by chemiluminescent-linked immunosorbent assay (CLIA) IgG S1/S2 and, later, positive cases using this technique were also analyzed to determine the rate of neutralization using the enzyme-linked immunosorbent assay (ELISA). We identified 40 CLIA IgG positive cases before the first official report of SARS-CoV-2 infection in Mexico. The national seroprevalence was 3.5% in February and 33.5% in December. Neutralizing activity among IgG positives patients during overall study period was 86.1%. The extent of the SARS-CoV-2 infection in Mexico is 21 times higher than that reported by molecular techniques. Although the general population is still far from achieving herd immunity, epidemiological indicators should be re-estimated based on serological studies of this type.

1 August 2019 in Acta Histochemica
Verified
Journal Article
Closed access
Ruth Madera-SandovalRuth Madera-Sandoval
Ruth Madera-Sandoval
JTJózsef Tóvári
József Tóvári
JLJózsef Lövey
József Lövey
IRIvan Ranđelović
Ivan Ranđelović
FOFausto Alejandro Jimenez Orozco
Fausto Alejandro Jimenez Orozco
AVArmando Vega-Loṕez
Armando Vega-Loṕez

1 October 2019 in Fish & Shellfish Immunology
Verified
Journal Article
Closed access
AVArmando Vega-Loṕez
Armando Vega-Loṕez
NPNataraj S. Pagadala
Nataraj S. Pagadala
BLBrenda P. López-Tapia
Brenda P. López-Tapia
Ruth Madera-SandovalRuth Madera-Sandoval
Ruth Madera-Sandoval
ERErika Rosales-Cruz
Erika Rosales-Cruz
ERElba Reyes-Maldonado
Elba Reyes-Maldonado

9 November 2023 in Clinical and Translational Science
Verified
Journal Article
Open access
Ruth Madera-SandovalRuth Madera-Sandoval
Ruth Madera-Sandoval
ACArturo Cerbulo
Arturo Cerbulo
LALourdes Andrea Arriaga-Pizano
Lourdes Andrea Arriaga-Pizano
GCGraciela Libier Cabrera‐Rivera
Graciela Libier Cabrera‐Rivera
EBEdna Basilio‐Gálvez
Edna Basilio‐Gálvez
EFEduardo Ferat‐Osorio
Eduardo Ferat‐Osorio
The difficulty in predicting fatal outcomes in patients with coronavirus disease 2019 (COVID‐19) impacts the general morbidity and mortality due to severe acute respiratory syndrome‐coronavirus 2 infection, as it wears out the hospital services that care for these patients. Unfortunately, in several of the candidates for prognostic biomarkers proposed, the predictive power is compromised when patients have pre‐existing comorbidities. A cohort of 147 patients hospitalized for severe COVID‐19 was included in a descriptive, observational, single‐center, and prospective study. Patients were recruited during the first COVID‐19 pandemic wave (April–November 2020). Data were collected from the clinical history whereas immunophenotyping by multiparameter flow cytometry analysis allowed us to assess the expression of surface markers on peripheral leucocyte. Patients were grouped according to the outcome in survivors or non‐survivors. The prognostic value of leucocyte, cytokines or HLA‐DR, CD39, and CD73 was calculated. Hypertension and chronic renal failure but not obesity and diabetes were conditions more frequent among the deceased patient group. Mixed hypercytokinemia, including inflammatory (IL‐6) and anti‐inflammatory (IL‐10) cytokines, was more evident in deceased patients. In the deceased patient group, lymphopenia with a higher neutrophil‐lymphocyte ratio (NLR) value was present. HLA‐DR expression and the percentage of CD39+ cells were higher than non‐COVID‐19 patients but remained similar despite the outcome. Receiver operating characteristic analysis and cutoff value of NLR (69.6%, 9.4), percentage NLR (pNLR; 71.1%, 13.6), and IL‐6 (79.7%, 135.2 pg/mL). The expression of HLA‐DR, CD39, and CD73, as many serum cytokines (other than IL‐6) and chemokines levels do not show prognostic potential, were compared to NLR and pNLR values.

5 August 2014 in Immunopharmacology and Immunotoxicology
Verified
Journal Article
Closed access
DUD. Italibi Uraga-Tovar
D. Italibi Uraga-Tovar
MDM. Lilia Domínguez-López
M. Lilia Domínguez-López
Ruth Madera-SandovalRuth Madera-Sandoval
Ruth Madera-Sandoval
MNMinerva Nájera-Martínez
Minerva Nájera-Martínez
EGEthel García-Latorre
Ethel García-Latorre
AVArmando Vega-Loṕez
Armando Vega-Loṕez
Halomethanes (HM) can be immunotoxic in mammals; however, in the fish immune system HM effects are unknown. In the current study, we evaluated the mitochondrial activity (MA) by MTT, induction of apoptosis by SubG0 technique and quantified serum ROS concentration (O2. and H2O2) and ROS production in PBMC of Cyprinus carpio carpio treated i.p. with CH2Cl2, CHCl3 and BrCHCl2 (0.004-40.0 mg/kg) for 96 h. Positive controls were recombinant heat shock protein of 60 kDa (rHSP60 kDa) of Klebsiella pneumoniae and its LPS. In addition, for in vitro PBMC cultures, two culture media and two sources of sera were tested. Both positive controls increased the MA more than 4-fold as well as the production of O2. (26-fold) and H2O2 (5-fold) compared to their controls. HM induced different effects on MA, ROS production and an induction of apoptosis, depending on the chlorination patterns and the dose; however, a systemic damage prevails. To fish treated with CH2Cl2, the apoptosis was related with serum ROS concentration and with MA. In contrast, in fish dosed with CHCl3 relationships were not found, deducing a systemic damage. However, in fish treated with BrCHCl2, serum O2. concentration and in vitro ROS generation performed by PBMC were involved in the induction of apoptosis of these cells but not with MA suggesting also immunotoxic effects. The current study demonstrated that HMs are immunomodulators increasing an acute inflammatory response and that rHSP60kDA of K. pneumoniae and its LPS are appropriate antigens to assess the immune response of C. c. carpio.